Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, May 3rd:
MSA Safety Incorporated (MSA - Free Report) : This manufacturer of safety products has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings advancing 10.3% over the last 60 days.
MSA Safety Incorporporated Price and Consensus
MSA’s shares gained 4.8% over the last one month more than S&P 500’s gain of 0.8%. The company possesses a Momentum Score of B.
MSA Safety Incorporporated Price
Commerce Bancshares, Inc. (CBSH - Free Report) : This bank holding company has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings advancing 7.1% over the last 60 days.
Commerce Bancshares, Inc. Price and Consensus
Commerce Bancshares’ shares gained 7.1% over the last one month. The company possesses a Momentum Score of B.
Commerce Bancshares, Inc. Price
WEX Inc. (WEX - Free Report) : This corporate card payment solutions provider has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings advancing 1.3% over the last 60 days.
WEX Inc. Price and Consensus
WEX’s shares gained 32.4% over the last one month. The company possesses a Momentum Score of A.
WEX Inc. Price
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.
5 Medical Stocks to Buy Now
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.
Click here to see the 5 stocks >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, May 3rd:
MSA Safety Incorporated (MSA - Free Report) : This manufacturer of safety products has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings advancing 10.3% over the last 60 days.
MSA Safety Incorporporated Price and Consensus
MSA’s shares gained 4.8% over the last one month more than S&P 500’s gain of 0.8%. The company possesses a Momentum Score of B.
MSA Safety Incorporporated Price
Commerce Bancshares, Inc. (CBSH - Free Report) : This bank holding company has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings advancing 7.1% over the last 60 days.
Commerce Bancshares, Inc. Price and Consensus
Commerce Bancshares’ shares gained 7.1% over the last one month. The company possesses a Momentum Score of B.
Commerce Bancshares, Inc. Price
WEX Inc. (WEX - Free Report) : This corporate card payment solutions provider has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings advancing 1.3% over the last 60 days.
WEX Inc. Price and Consensus
WEX’s shares gained 32.4% over the last one month. The company possesses a Momentum Score of A.
WEX Inc. Price
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.
5 Medical Stocks to Buy Now
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.
Click here to see the 5 stocks >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on CBSH - FREE
Get the latest research report on WEX - FREE
Get the latest research report on MSA - FREE